Curing both rare diseases and common cancers doesn't just require new research, but also linking all the data that researchers already have.
Modern medicine is incredibly data-intensive, especially now that doing a full genetic sequencing of every patient is becoming affordable and more prevalent. New efforts to develop tailored treatments for illnesses—known as precision medicine—will require collecting and sharing data on a hard-to-comprehend scale. That's the biggest takeaway from the White House Precision Medicine Initiative (PMI) Summit.